ScholarLens Back to search
2009•Laboratory Medicine and ClinicRequires access

Clinical observation of hemoperfusion for hepatic hyperbilirubinamia

Yuan Chun-lan

Open publisher page 0 citations

Abstract

Objective To observe the efficacy and safety of hemoperfusion for hepatic hyperbilirubinamia(TBIL≥171 μmol/L).Methods 25 patients of hepatic hyperbilirubinamia received the treatment with HA neutral macroporous resin(HA330-Ⅱ)hemoperfusion and medical treatment.The symptoms,signs and levels of liver functions,complete blood counts were compared before and after treatment.The adverse reaction of hemoperfusion was also monitored.Results After hemoperfusion,the symptoms and signs were improved to different extents;the levels of ALT,AST,TBIL,DBIL decreased significantly(P0.05);the levels of RBC,WBC,PLT went down slightly(P0.05).There were no significant adverse reaction in the course of hemoperfusion.Conclusion Hemoperfusion is an effective and safe therapy for hepatic hyperbilirubinamia.

About this research paper

What this paper is about

Objective To observe the efficacy and safety of hemoperfusion for hepatic hyperbilirubinamia(TBIL≥171 μmol/L).Methods 25 patients of hepatic hyperbilirubinamia received the treatment with HA neutral macroporous resin(HA330-Ⅱ)hemoperfusion and medical treatment.The symptoms,signs and levels of liver functions,complete blood counts were compared before and after treatment.The adverse reaction of hemoperfusion was also monitored.Results After hemoperfusion,the symptoms and signs were improved to different extents;the levels of ALT,AST,TBIL,DBIL decreased significantly(P0.05);the levels of RBC,WBC,PLT went down slightly(P0.05).There were no significant adverse reaction in the course of hemoperfusion.Conclusion Hemoperfusion is an effective and safe therapy for hepatic hyperbilirubinamia.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the efficacy and safety of hemoperfusion for hepatic hyperbilirubinamia(TBIL≥171 μmol/L).Methods 25 patients of hepatic hyperbilirubinamia received the treatment with HA neutral macroporous resin(HA330-Ⅱ)hemoperfusion and medical treatment.The symptoms,signs and levels of liver functions,complete blood counts were compared before and after treatment.The adverse reaction of hemoperfusion was also monitored.Results After hemoperfusion,the symptoms and signs were improved to different extents;the levels of ALT,AST,TBIL,DBIL decreased significantly(P0.05);the levels of RBC,WBC,PLT went down slightly(P0.05).There were no significant adverse reaction in the course of hemoperfusion.Conclusion Hemoperfusion is an effective and safe therapy for hepatic hyperbilirubinamia.

Key concepts: Hemoperfusion, Adverse effect, Medicine, Gastroenterology, Internal medicine, Pharmacology, Anesthesia, Hemodialysis

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical observation of hemoperfusion for hepatic hyperbilirubinamia — Research Paper | ScholarLens